AAAAAA

   
Results: 1-4 |
Results: 4

Authors: Pautas, E Siguret, V d'Urso, M Laurent, M Gaussem, P Fevrier, M Durand-Gasselin, B
Citation: E. Pautas et al., Monitoring of tinzaparin treatment at treatment dose of 10 days in elderlypatients, REV MED IN, 22(2), 2001, pp. 120-126

Authors: Lecoeur, H Fevrier, M Garcia, S Riviere, Y Gougeon, ML
Citation: H. Lecoeur et al., A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity, J IMMUNOL M, 253(1-2), 2001, pp. 177-187

Authors: Siguret, V Pautas, E Fevrier, M Wipff, C Durand-Gasselin, B Laurent, M Andreux, JP d'Urso, M Gaussem, P
Citation: V. Siguret et al., Elderly patients treated with tinzaparin (Innohep (R)) administered once daily (175 anti-Xa IU/kg): Anti-Xa and anti-IIa activities over 10 days, THROMB HAEM, 84(5), 2000, pp. 800-804

Authors: Le Borgne, S Fevrier, M Callebaut, C Lee, SP Riviere, Y
Citation: S. Le Borgne et al., CD8(+)-cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription, J VIROLOGY, 74(10), 2000, pp. 4456-4464
Risultati: 1-4 |